课题基金 / 基金详情

UNDERSTANDING MECHANISMS OF HCV PERSISTENCE

UNDERSTANDING MECHANISMS OF HCV PERSISTENCE
了解 HCV 持续存在的机制
批准号:
8172414
负责人:
Arash Grakoui
金额:
$4.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30

项目摘要

项目成果

Arash Grakoui的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Our work is designed to identify the defect in the host immune response responsible for the inability of the remaining 80% to naturally clear HCV infection. We hypothesized that the cellular immune response is the principal determinant of whether HCV infection is acutely resolved or establishes persistence and we are seeking to elucidate and understand the essential components of an effective anti-HCV immune response. We are utilizing a large cohort of chronically infected human patients, as well as novel cell culture systems to dissect the anti-HCV immune response. We began building a cohort of patients undergoing liver transplantation for HCV related liver failure. This cohort comprises patients with a wide variety of fibrosis scores, not just cirrhosis. We were able to obtain large wedge samples from both the donor and recipient livers allowing comprehensive phenotypic and some functional analysis of the intrahepatic immune response to HCV. We identified phenotypic markers of anti-HCV liver infiltrating T cells that correlate with T cell dysfunction that may be targets for immune augmentation. We described an increased propensity of HCV specific cells to undergo massive apoptosis in the peripheral blood during acute infection and in the liver during chronic infection as well as a critical balance between molecules facilitating immune stimulation and inhibition. The ability to follow transplant patients longitudinally is critical, since the majority will again manifest HCV viremia. This unique window into the infection timeline is allowing us unprecedented assessment of the immune response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Correlates of protective immunity to HCV and rational vaccine design
  • 批准号:
    10393614
  • 项目类别:
  • 资助金额:
    $204.03万
  • 财政年份:
    2021
  • 负责人:
    Arash Grakoui
  • 依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Admin Core
  • 批准号:
    10393615
  • 项目类别:
  • 资助金额:
    $40.81万
  • 财政年份:
    2021
  • 负责人:
    Arash Grakoui
  • 依托单位:
Correlates of protective immunity to HCV and rational vaccine design
  • 批准号:
    10205764
  • 项目类别:
  • 资助金额:
    $201.88万
  • 财政年份:
    2021
  • 负责人:
    Arash Grakoui
  • 依托单位:
Correlates of protective immunity to HCV and rational vaccine design: Project 2
  • 批准号:
    10205768
  • 项目类别:
  • 资助金额:
    $73.75万
  • 财政年份:
    2021
  • 负责人:
    Arash Grakoui
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: